Search

everythinglearnresearchcommunity

for

Search:↓

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

Finasteride reduces prostate size and PSA levels in young patients.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

New regenerative therapies show promise for treating hair loss.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Ganoderma lucidum extract may help treat stress-related hair loss.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Fulvestrant at 10 mg/kg does not promote hair regrowth in dogs with alopecia X.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.